Big Endothelin-1 (1 – 31) (Human)

Big Endothelin-1 (1 – 31) (Human)

0.1 mg
€198,00

Sie können eine Angebotsanfrage erstellen, nachdem Sie das Produkt in den Warenkorb gelegt haben.

Zu Produktinformationen springen
Big Endothelin-1 (1 – 31) (Human)

Big Endothelin-1 (1 – 31) (Human)

Produkt-ID: 4360

Cys – Ser – Cys – Ser – Ser – Leu – Met – Asp – Lys – Glu – Cys – Val – Tyr – Phe – Cys – His – Leu – Asp – Ile – Ile – Trp – Val – Asn – Thr – Pro – Glu – His – Val – Val – Pro – Tyr

€198,00
exkl. 19% MwSt.
Quantity
Beschreibung

Big ET-1 (1-31) (human, bovine)

M.W. 3628.2

C162H236N38O47S5

133972-52-8

Cys – Ser – Cys – Ser – Ser – Leu – Met – Asp – Lys – Glu – Cys – Val – Tyr – Phe – Cys – His – Leu – Asp – Ile – Ile – Trp – Val – Asn – Thr – Pro – Glu – His – Val – Val – Pro – Tyr

Big Endothelin-1 (1-31) is an endogenous form of Endothelin-1. The 31 mer oligopeptide is generated by chymase hydolysation from its precursor. This conversation process can be blocked with Phosphoramidon, which is a potent endothelin-converting-enzyme inhibitor. The conversation from Big Endothelin-1 (1-31) into Endothelin 1 will not be effected.The biological activity of Big Endothelin-1 (1 – 31) is examined by the Division of Pharmacology, Peptide Institute, Inc.

Synthetic Product (disulfide bonds between Cys1-Cys15 and Cys3-Cys11)

The purity is guaranteed to be higher than 99% by HPLC

Referenzen:

1. A. Nakano, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido, J. Immunol, 159, 1987 (1997) (Original; New Endogenous Form) 2. F. Kishi, K. Minami, N. Okishima, M. Murakami, S. Mori, M. Yano, Y. Niwa, Y. Nakaya, and H. Kido, Biochem. Biophys. Res. Commun., 248, 387 (1998) (Pharmacol.) 3. M. Yoshizumi, D. Inui, N. Okishima, H. Houchi, K. Tsuchiya, H. Wakabayashi, H. Kido, and T. Tamaki, Eur. J. Pharmacol., 348, 305 (1998) (Pharmacol.) 4. M. Yoshizumi, S. Kim, S. Kagami, A. Hamaguchi, K. Tsuchiya, H. Houchi, H. Iwao, H. Kido, and T. Tamaki, Br. J. Pharmacol., 125, 1019 (1998) (Pharmacol.)

You may also like